Novo Nordisk Settles Trademark Dispute with Ohio Clinic Over Compounded Medications

Novo Nordisk, renowned for its blockbuster weight loss drugs including Ozempic, Rybelsus, and Wegovy, has reached an agreement with a clinic in Ohio to resolve a federal trademark infringement suit. This case was part of a series of legal actions pursued by the pharmaceutical corporation against medical facilities offering custom-made compounded drugs, claiming them to have effects similar to Novo Nordisk’s products. The details of the settlement remain undisclosed, but this legal development underscores the pharmaceutical giant’s commitment to protecting its brand and intellectual property against unauthorized compositions. For further details, please refer to the complete article.